Task X12: Evaluation of Human Tissue Cross-reactivity of Phase I Clinical Trial Serum Samples

任务X12：I期临床试验血清样本的人体组织交叉反应性评估

• 批准号: 9151775
• 负责人: MARY BRUCE
• 金额: $ 26.86万
• 依托单位: BATTELLE CENTERS/PUB HLTH RES & EVALUATN
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-04-23 至 2017-01-22
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9151775
• 关键词: Clinical; Contracts; Development; Evaluation; National Institute of Allergy and Infectious Disease; Phase I Clinical Trials; Sampling; Serum; Services; Testing; Translational Research; Vaccines; cross reactivity; evaluation/testing; human tissue; pre-clinical; programs

This contract provides for clinical and nonclinical sample testing for STREPTOCOCCI GROUP A vaccines and other biologics under the NIAID Preclinical Services for Evaluation and Testing Serves (ETS) Program.

该合同规定在NIAID评估和测试服务（ETS）项目的临床前服务下，对A组链球菌疫苗和其他生物制剂进行临床和非临床样品检测。